vs
Himalaya Shipping Ltd.（HSHP）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Himalaya Shipping Ltd.的季度营收约是STANDARD BIOTOOLS INC.的1.5倍（$29.9M vs $19.6M），Himalaya Shipping Ltd.净利率更高（3.7% vs -177.4%，领先181.1%），Himalaya Shipping Ltd.同比增速更快（-4.2% vs -11.5%）
喜马拉雅航运有限公司是一家专注干散货运输的全球海运企业，运营节能环保型现代散货船船队，主要运输铁矿石、煤炭、粮食等大宗原材料，服务覆盖亚欧、美洲核心贸易航线，为全球工农业供应链提供运力支持。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
HSHP vs LAB — 直观对比
营收规模更大
HSHP
是对方的1.5倍
$19.6M
营收增速更快
HSHP
高出7.3%
-11.5%
净利率更高
HSHP
高出181.1%
-177.4%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.9M | $19.6M |
| 净利润 | $1.1M | $-34.7M |
| 毛利率 | 76.3% | 48.5% |
| 营业利润率 | 45.5% | -168.5% |
| 净利率 | 3.7% | -177.4% |
| 营收同比 | -4.2% | -11.5% |
| 净利润同比 | -84.1% | -28.8% |
| 每股收益（稀释后） | $0.02 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSHPLAB
| Q3 25 | — | $19.6M | ||
| Q2 25 | $29.9M | $21.8M | ||
| Q1 25 | — | $40.8M | ||
| Q3 24 | — | $22.1M | ||
| Q2 24 | $31.2M | $22.5M | ||
| Q1 24 | — | $45.5M | ||
| Q4 23 | — | $28.2M | ||
| Q3 23 | — | $25.4M |
净利润HSHPLAB
| Q3 25 | — | $-34.7M | ||
| Q2 25 | $1.1M | $-33.5M | ||
| Q1 25 | — | $-26.0M | ||
| Q3 24 | — | $-26.9M | ||
| Q2 24 | $6.9M | $-45.7M | ||
| Q1 24 | — | $-32.2M | ||
| Q4 23 | — | $-19.8M | ||
| Q3 23 | — | $-21.0M |
毛利率HSHPLAB
| Q3 25 | — | 48.5% | ||
| Q2 25 | 76.3% | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | 82.1% | 46.1% | ||
| Q1 24 | — | 53.1% | ||
| Q4 23 | — | 47.6% | ||
| Q3 23 | — | 44.0% |
营业利润率HSHPLAB
| Q3 25 | — | -168.5% | ||
| Q2 25 | 45.5% | -118.1% | ||
| Q1 25 | — | -80.8% | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | 56.1% | -134.5% | ||
| Q1 24 | — | -132.2% | ||
| Q4 23 | — | -75.9% | ||
| Q3 23 | — | -83.5% |
净利率HSHPLAB
| Q3 25 | — | -177.4% | ||
| Q2 25 | 3.7% | -153.7% | ||
| Q1 25 | — | -63.8% | ||
| Q3 24 | — | -122.0% | ||
| Q2 24 | 22.1% | -203.3% | ||
| Q1 24 | — | -70.6% | ||
| Q4 23 | — | -70.2% | ||
| Q3 23 | — | -82.8% |
每股收益（稀释后）HSHPLAB
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $0.02 | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | $0.16 | $-0.12 | ||
| Q1 24 | — | $-0.27 | ||
| Q4 23 | — | $-0.24 | ||
| Q3 23 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.7M | $129.4M |
| 总债务越低越好 | $701.3M | — |
| 股东权益账面价值 | $159.3M | $399.7M |
| 总资产 | $871.9M | $539.6M |
| 负债/权益比越低杠杆越低 | 4.40× | — |
8季度趋势，按日历期对齐
现金及短期投资HSHPLAB
| Q3 25 | — | $129.4M | ||
| Q2 25 | $24.7M | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | $21.9M | $269.8M | ||
| Q1 24 | — | $287.1M | ||
| Q4 23 | — | $51.7M | ||
| Q3 23 | — | $79.7M |
总债务HSHPLAB
| Q3 25 | — | — | ||
| Q2 25 | $701.3M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | $725.5M | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M | ||
| Q3 23 | — | $64.6M |
股东权益HSHPLAB
| Q3 25 | — | $399.7M | ||
| Q2 25 | $159.3M | $424.5M | ||
| Q1 25 | — | $454.6M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | $157.2M | $510.3M | ||
| Q1 24 | — | $577.3M | ||
| Q4 23 | — | $-148.1M | ||
| Q3 23 | — | $-131.7M |
总资产HSHPLAB
| Q3 25 | — | $539.6M | ||
| Q2 25 | $871.9M | $557.0M | ||
| Q1 25 | — | $579.6M | ||
| Q3 24 | — | $681.5M | ||
| Q2 24 | $897.3M | $708.7M | ||
| Q1 24 | — | $777.7M | ||
| Q4 23 | — | $323.1M | ||
| Q3 23 | — | $339.3M |
负债/权益比HSHPLAB
| Q3 25 | — | — | ||
| Q2 25 | 4.40× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | 4.61× | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | 7.55× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流HSHPLAB
| Q3 25 | — | $-22.2M | ||
| Q2 25 | $8.3M | $-20.7M | ||
| Q1 25 | — | $-30.3M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | $17.6M | $-39.0M | ||
| Q1 24 | — | $-62.5M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-11.4M |
自由现金流HSHPLAB
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | — | $-12.3M |
自由现金流率HSHPLAB
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% | ||
| Q3 23 | — | -48.6% |
资本支出强度HSHPLAB
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% | ||
| Q3 23 | — | 3.6% |
现金转化率HSHPLAB
| Q3 25 | — | — | ||
| Q2 25 | 7.55× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.55× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSHP
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
